Access to anti-retroviral drugs, male in Spain
Spain: Access to anti-retroviral drugs, male was 91.0% in 2022. ▲ Rising
Access to anti-retroviral drugs, male in Spain, 2000–2022
Source: UNAIDS estimates. Measured in %.
Analysis
In 2022, access to anti-retroviral drugs, male in Spain stood at 91.0%. That is the highest value across all 23 years on record.
That represents a change of up 3.4% on the previous year and up 37.9% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Spain peaked at 91.0% in 2022 and was at its lowest, 25.0%, in 2000.
Spain ranks 12th of 141 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 23 years of available data.
Access to anti-retroviral drugs, male in Spain, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 25.0% | — |
| 2001 | 29.0% | +16.0% |
| 2002 | 33.0% | +13.8% |
| 2003 | 37.0% | +12.1% |
| 2004 | 41.0% | +10.8% |
| 2005 | 44.0% | +7.3% |
| 2006 | 47.0% | +6.8% |
| 2007 | 50.0% | +6.4% |
| 2008 | 54.0% | +8.0% |
| 2009 | 57.0% | +5.6% |
| 2010 | 62.0% | +8.8% |
| 2011 | 63.0% | +1.6% |
| 2012 | 66.0% | +4.8% |
| 2013 | 68.0% | +3.0% |
| 2014 | 70.0% | +2.9% |
| 2015 | 73.0% | +4.3% |
| 2016 | 81.0% | +11.0% |
| 2017 | 82.0% | +1.2% |
| 2018 | 84.0% | +2.4% |
| 2019 | 85.0% | +1.2% |
| 2020 | 87.0% | +2.4% |
| 2021 | 88.0% | +1.1% |
| 2022 | 91.0% | +3.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 41.7% | 25.0% | 57.0% | 10 |
| 2010s | 73.4% | 62.0% | 85.0% | 10 |
| 2020s | 88.7% | 87.0% | 91.0% | 3 |
Countries ranked near Spain
More gender data for Spain
- Child population (UN estimates and projections) 5,413 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.09 % change on previous year (2030)
- Population 42,197 (2030)
- Working-age population (UN estimates and projections) 42,197 (2030)
- Population (UN estimates and projections), annual growth rate 0.0961 % change on previous year (2030)
- Age population, age 00, female, interpolated 161,756 (2025)
- Age population, age 00, male, interpolated 171,794 (2025)
- Age population, age 01, female, interpolated 164,221 (2025)
- Age population, age 01, male, interpolated 174,083 (2025)
- Age population, age 02, female, interpolated 166,341 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Spain?
- Access to anti-retroviral drugs, male in Spain was 91.0% in 2022, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Spain?
- The highest recorded value was 91.0% in 2022.
- What is the lowest access to anti-retroviral drugs, male recorded in Spain?
- The lowest recorded value was 25.0% in 2000.
- How does Spain rank for access to anti-retroviral drugs, male?
- Spain ranks 12th out of 141 countries with data for 2022.
- Is access to anti-retroviral drugs, male rising or falling in Spain?
- Over the last ten years it is up 37.9%. The long-run trend across the full record is rising.
- Where does this Spain data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.